Oncology Conferences 2019 | Cancer Conferences 2019 in Switzerland

Theme: Battle together for a Cancer free World

Medical Oncology-2019

Medical Oncology-2019

After the successful completion of 30 conferences in the field of Cancer Research and therapy we would like to welcome everyone from the field of cancer research, oncology therapy to the Conference named 31^st International Conference on Cancer Research and therapy which is scheduled to be held in Zurich, Switzerland in the month of September.

2018 Highlights:

· 150+ Participation (70 Industry: 30 Academia)

· 10+ Keynote Speakers

· 20+ Exhibitors

· 5+ Workshops

· B2B Meetings

Cancer Research 2019 has everything you need:

A symposium: casual gathering and includes refreshments and entertainment.

A seminar: discussing the recent research and therapy which is going on in the cancer field.

A workshop: Providing a Valuable Platform for the Speakers and as well as Young research forums to elaborate their respective research work

Round table meetings: Providing a platform where industry professionals meet academic experts.

Target Audience:

· Oncologists

· Radiologists

· Immunologists

· Pathologists

· Molecular Biologists

· Clinical Oncology Researchers

· Oncology Nurses

· Cancer Researchers

· Young Researchers

· Undergraduates

· Biomarker Associations and Societies

· Business Entrepreneurs

· Research Companies

· Diagnostics Companies

*Track 1**: Cancer Research*

Malignant growth investigate is an examination of mischief to see causes and make structures for killing action, examination, treatment, and fix. Tumor explores ranges from the examination of ailment transmission, sub-atomic bioscience to the execution of clinical groundworks to assess and consider the utilization of the unmistakable advancement drugs. These applications intertwine restorative system, radiation treatment, chemotherapy, hormone treatment, and immunotherapy, and joined treatment modalities, for example, chemo-radiotherapy. Beginning in the mid-1990s, the accentuation in clinical damage get some information about moved towards meds got from biotechnology research, for example, tumor immunotherapy and quality treatment.

Translational potential

Industry beckons

Contact Inhibition

Evade Apoptosis

Cancer Cell Metabolism

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 2: Cancer Genetics

Cancer is a genetic contamination initiated by a development of DNA changes and epigenetic adjustments that prompts uncontrolled cell duplication and neoplasm course of action. The change happens a significant part of the time in the gathering of human still it can prepared to cure an expansive segment of the changes. Along these lines, it won't be possible to cause malignant growth with one change. Generally, it takes different changes in a lifetime of a human to cause disease. This is the reason senior people have malignant growth, as they have had different potential outcomes for change. Oncogenomic deals with the depiction of malignancy related characteristics. Tumor silencer characteristics or oncogenes are the ones that manage the telephone cycle process, so they are known as the guarded cells. These genetic changes elevate the threat of malignant growth. The proximity of changed characteristics in germ cells can be gained to the offsprings. Malignant growth Pharmacology deals with the action of the drug on disease patients. Malignant growth science Meetings examines the new contemplations and strategies of disease treatment

Li-Fraumeni syndrome

Adenomatous polyposis

Retinoblastoma

Von Hippel-Lindau syndrome

Lynch Syndrome

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

*Track 3:**Cancer Epigenetics*

Malignant growth epigenetics is the examination of epigenetic changes to the DNA of disease cells that do exclude a modification in the nucleotide course of action. Epigenetic changes may be comparable as goal, or essentially progressively basic, than innate changes in a cell's change to malignant growth. In malignant growths, loss of explanation of characteristics occurs around multiple times even more in many cases by interpretation calming (brought about by epigenetic advertiser hypermethylation of CpG islands) than by changes. As Vogelstein et al. point out, in colorectal disease, there are generally around 3 to 6 driver changes and 33 to 66 vagabond or explorer changes. Regardless, in colon tumors stood out from neighboring conventional appearing to be colonic mucosa, there are around 600 to 800 seriously methylated CpG islands in advertisers of characteristics in the tumors while these CpG islands are not methylated in the coterminous mucosa.

DNA methylation.

Pyro-sequencing

Chromatin Immunoprecipitation Assay

Prostate Cancer

Cervical cancer

*Track 4:**Cancer Science*

Malignant growth Science is a wide field that plans with disease research and treatment. Malignant growth, when considered as a deadly disease, yet at this point with an improvement in malignancy ask about the condition has changed. It is viewed as an enormous achievement as there are particular medicines open as of now to treat and break down malignant growth. The concentrated on malignant growth treatment is a standout amongst the best medications in seeing disease as it incorporates, the treating of the malignant growth cells by concentrating on and limiting the specific particles that are a necessity for the tumor development. This blocking should be conceivable by sub-nuclear drug. The Cancer Case Reports shows the undeveloped cell treatment as a working treatment of disease. Disease biomarkers help in finding tumor cells and treating them. Tumor Immunology expect a basic occupation in a finding of new philosophies for malignant growth therapeutics. Disease Conferences imparts its push to give up malignancy from the world.

Cancer Epigenome

Carcinoma

Sarcoma

Molecular Oncology

Bronchial Oncology

Oesophageal Cancer

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 5: Cancer Diagnostics

The overall malignant growth diagnostics grandstand expansion was regarded at USD 124.0 billion of each 2016 and is depended upon to create at a CAGR of 7.2% over the figure time period. Compelled diagnostics movements have accomplished a decreasing of 30% in chest malignancy. Henceforward, the imaging part in the in general Oncological diagnostics market will continue with its everlasting inside a reasonable time length. The general Cancer Diagnostics Market can be circulated into blood malignancy, kidney infection, chest disease, prostate improvement, pancreatic advancement, ovarian tumor, lung disease, and liver malignant growth. The general disease diagnostics promote is generally assessed by improving the energy for lung malignancy and chest malignant growth examination. The lung disease region is driving the market, as it is the most common kind of risk.

Barium Enema

Colonoscopy

Bronchoscopy

Conization

Digital Rectal Exam

Esophagoscopy

Gallium Scan

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Cancer immunotherapy (every so often called immuno-oncology) is the fake actuation of the resistant system to treat disease. It is an utilization of the key research of disease immunology and a creating subspecialty of oncology. It mishandles the manner in which that malignant growth cells routinely have iotas on their surface that can be distinguished by the insusceptible system, known as tumor antigens; they are much of the time proteins or distinctive macromolecules (for example sugars). Immunotherapies can be orchestrated as a dynamic, uninvolved or mutt (dynamic and standoffish). Dynamic immunotherapy controls the resistant system to ambush tumor cells by concentrating on tumor antigens. Inert immunotherapies update existing adversary of tumor responses and consolidate the use of monoclonal antibodies, lymphocytes, and cytokines.

Non-specific immunotherapies

T-cell therapy

Tumor microenvironment

Clonal Immune system

Synthetic Biology

Chimeric antigen receptor

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 13: Cancer Operamics

The conspicuous verification of coding progressions in different species, fusing human as soon as possible, has presented the post-genome period. In this time, progressions are getting the chance to be available that license the profiling of tissues and cell peoples at the genomic, transcriptomic and proteomic levels. The nuclear examination of tissues at all three dimensions has been insinuated as operomics. This review covers some fundamental developments for operomics and their application to some lymphoid issue. It is proposed that no one kind of examination is totally informative and that information that can be gotten from the differing compartments wrapped in operomics is complimentary. Prospects for carrying such profiling advances into the clinical research office will depend upon their quality, their usability and the clinical noteworthiness of the extra information they give, which can't be gotten through various advances being utilized in the clinical lab.

Intelligent Demand Forecasting

Automated Quality Control

Predictive Analytics

Customer Segmentation

Proteomics Profiling

Genetic Translation Process

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 14: Carcinogenesis

Of late new enhancements in cytogenetic, immunophenotyping and sub-atomic science have fundamentally moved our perception of leukemia. Shockingly, standard morphologic evaluation of extreme myeloblastic leukemia using the French-American-British portrayal compares ineffectually with an extensive segment of this new information and does not foresee the response to treatment. In this review, we center around employments of sub-atomic biologic systems to the assurance of leukemia and look at usage of this advancement to distinguish the inconsequential waiting sickness. We by then present an altered gathering for extraordinary myeloblastic leukemia as demonstrated by whether myelodysplasia-like features are accessible or lacking. Cases may then be furthermore described using French-American-British morphology and distinctive parameters. This gathering appears to relate better with new biologic data and with therapeutic response.

Immune Checkpoint Inhibitors

Adoptive Immunotherapy

Therapeutic Antibodies

Immune-Modulating Agents

Oncornavirus Expression

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 15: Cancer Nursing care

Cancer Nursing is a field including practice wraps the employment of the direct parental figure, teacher, consultant, chief, and researcher. Disease nursing connects with all mind transport settings where clients experiencing or in peril of making malignancy get human administrations, preparing, and prompting for malignancy neutralizing activity, screening and ID. It furthermore incorporates fitting screenings and other defend sharpens, indication organization, care to hold anyway much normal filling in as could sensibly be normal, and solid measures upon the completion of life.

Symptom Management

Supportive Care

Patient Assessment

Quality Nursing Care

Cancer Related Fatigue

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 16: Cancer awareness

Extended disease care improves survival. Social and Economic Impact also hurt the idea of malignant growth care. People who are monetarily not strong don't get incredible treatment. Malignant growth reaction care and disease survival are connected. Disease Awareness Program is coordinated by the organization and various relationship to procure the care the all inclusive community to decrease the malignant growth levels and towards all oncology programs. Campaigns should focus on upgrading care about malignant growth signs, especially in monetarily denied regions.

Melanoma

Small molecule drugs

Monoclonal antibodies

Sigmoidoscopy

Upper endoscopy

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 17: Experimental Therapeutics

Exploratory therapeutics is the headway of treatment frameworks that even more feasible and especially treat human disease with less peril. Research in test therapeutics organizes distinctive instructs to fathom the illness from the sub-nuclear to organismal dimensions and a while later undertakings to apply this data to recognize and favor targets, find and make interventions or meds to control these destinations, and finally drive preclinical and clinical examinations to accomplish the goal of the redid sedate.

Drug delivery systems

Safety Pharmacology

Clinical pharmacology

Research methodologies

Regenerative Medicine

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 18: Organ-Specific Cancer

The bit of genomics that perceives malignancy joined characteristics was identified with oncogenomics. It centers around epigenetic, genomic, and record changes in malignant growth. The progress from normal tissue to undermining malignant growth was thought to occur over a period of 5– 20 years. Obtained genetic factors, significant inherited modifications, and changes change were settled, and it results in uncontrolled cell improvement and prompts passing. Malignancy causing characteristics have been delegated proto-oncogenes (e.g., the characteristics for MYC, ERBB2, and EGFR) and tumor silencer characteristics, for instance, the characteristics that encode TP53, CDKN2A, and RB. The accomplishment of the Human Genome Project streamlined the field of oncogenomics and improved the capacities of researchers to the disclosure of oncogenes.

Hereditary cancer Syndrome

Microarray

Mutation Genomics Strategies

Networking inhibitors

Metabolic normalization

Generic drivers

Warburg effect

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

*Track 19:**Radiation therapy*

As a general term, radiation suggests deluges of imperativeness, for instance, light or warmth. The sort of radiation used in malignant growth treatment is a high-imperativeness creates known as ionizing radiation. Definitely how radiation works as a treatment for disease are amazing but then being analyzed, anyway on a clear dimension it isolates the DNA of malignancy cells in a manner that bothers their improvement and division and can even execute them. Radiation treatment will all over be used without any other individual, and once in a while will be used close by other disease meds, for instance, chemotherapy, if a malignant growth ace picks that this will update the effect of the treatment. About 60 for every penny of people being managed for malignancy in the United States will get radiation treatment.

Image-guided radiation therapy

3-D conformal

Intensity-modulated radiation therapy

Tomotherapy

Stereotactic radiosurgery

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 20: Cancer alternative Medicine

Cancer treatments incorporate Complementary and Alternative Medicine, which are for the most part non-standard practices. As of late, CAM treatments are picking up significance in overseeing unfavourable manifestations of Cancer. In the event that a non-standard treatment is utilized together with the customary drug, it's considered as "Reciprocal treatment." If a non-standard treatment is utilized instead of ordinary pharmaceutical, it's considered as "Elective treatment." CAM comprises medications that depend on prescientific ideas of human physiology and pathology. A great many people who utilize non-standard methodologies utilize them alongside customary medications. CAM treatments incorporate a wide assortment of botanicals and healthful items, for example, dietary enhancements, natural enhancements, and vitamins.

Hypnotherapy

Cancer pain

Acupuncture

Chiropractic

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

Track 21: Cancer Survivors

We can call dietary as eating routine treatment. As it is a technique for giving the most ideal sustenance to the patient supported by the masters. Treatment of the patient incorporates sustenance for an unrivaled condition of the prosperity. As a result of disease patients, thin down is fundamental to make due for an all-encompassing stretch. Picking right kind of the sustenance when malignant growth treatment is crucial. As the malignancy patient ought to require all of the nutrients and likewise sustenance. The moment that the body isn't outfitted with the most ideal sustenance then the patient will encounter the evil impacts of the weak wellbeing. In a couple of conditions, the tumors in our body make synthetics that occupy the strategy for enhancements use. Malignant growth meds make the patient harder to eat up the sustenance and nutrient. The responses brought about by the treatment of disease.

Detection of new cancers

Surveillance for recurrence

Managing psychosocial and medical late effects

Genetic risk assessment

Promoting self-management

European Cancer Universities:

USA Cancer Universities

Asian Cancer Universities

The improvement in the treatment of tumor is quickly growing all through the worldwide market. The present report centers around the overall oncodiagnostics showcase for the gauge time of 2015 to 2020. This market is required to reach $13.1 Billion by 2020 from $7.1 Billion out of 2015, and is prepared to create at a CAGR of 12.9% amid the assessed day and age. The overall threat diagnostics showcase will bring a fast change by making a remarkable movement in the field of innovation identified with oncodiagnostic advertise.

Oncology is the examination of infection. An authority who has down to earth involvement in treating people with malady is called an oncologist. When in doubt, an oncologist regulates care and treatment once a man is resolved to have threat.

The bosom danger therapeutics grandstand in the Asia-Pacific countries of India, Australia, China and New-Zealand was worth $1.5 billion of every 2013 and is required to create at a Compound Annual Growth Rate of 7.6% to $1.5 billion by 2020. New-zealand had the greatest market in 2013 with an estimation of $872m, or an offer of 48%, trailed by China with $320m or 21%, and Australia with $234m or 15%. India had the most decreased bit of the pie and regard at 5%, yet is depended upon to witness the snappiest advancement over the figure time span with an of 10.8%, appeared differently in relation to Australia at 5.8% and China and New-zealand both at 7.7%.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 09-10, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

31^st International Conference on Cancer Research and Therapy September 09-10, 2019 Zurich,Switzerland

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links